ZA9610457B - Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man - Google Patents

Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man

Info

Publication number
ZA9610457B
ZA9610457B ZA9610457A ZA9610457A ZA9610457B ZA 9610457 B ZA9610457 B ZA 9610457B ZA 9610457 A ZA9610457 A ZA 9610457A ZA 9610457 A ZA9610457 A ZA 9610457A ZA 9610457 B ZA9610457 B ZA 9610457B
Authority
ZA
South Africa
Prior art keywords
emesis
sleeps
piperazinyl
heteroaryl
medicament
Prior art date
Application number
ZA9610457A
Other languages
English (en)
Inventor
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of ZA9610457B publication Critical patent/ZA9610457B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
ZA9610457A 1995-12-12 1996-12-12 Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man ZA9610457B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514690A FR2742052B1 (fr) 1995-12-12 1995-12-12 Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports

Publications (1)

Publication Number Publication Date
ZA9610457B true ZA9610457B (en) 1997-06-24

Family

ID=9485400

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610457A ZA9610457B (en) 1995-12-12 1996-12-12 Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man

Country Status (16)

Country Link
EP (1) EP0808166A1 (cs)
JP (1) JPH11501051A (cs)
CN (1) CN1177297A (cs)
AR (1) AR004378A1 (cs)
AU (1) AU716665B2 (cs)
CA (1) CA2211161A1 (cs)
CZ (1) CZ255197A3 (cs)
ES (1) ES2134709B1 (cs)
FR (1) FR2742052B1 (cs)
HU (1) HUP9800198A2 (cs)
IL (1) IL121461A0 (cs)
NO (1) NO973589L (cs)
PL (1) PL321779A1 (cs)
TR (1) TR199700794T1 (cs)
WO (1) WO1997021439A1 (cs)
ZA (1) ZA9610457B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763950B1 (fr) 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
HK1052705B (en) 2000-08-14 2006-09-29 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazole
EP1309591B1 (en) 2000-08-14 2007-01-24 Ortho-McNeil Pharmaceutical, Inc. Substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
EP1309593B1 (en) 2000-08-14 2006-03-15 Ortho-McNeil Pharmaceutical, Inc. Substituted pyrazoles
US6369032B1 (en) 2000-09-06 2002-04-09 Ortho-Mcneil Pharmaceutical, Inc. Method for treating allergies
EP1715921B1 (en) 2003-09-25 2013-04-24 Abraxis BioScience, Inc. Tetrahydroindolone derivatives for treatment of neurological conditions
WO2005094827A1 (en) * 2004-03-30 2005-10-13 Kestrel Pharmaceuticals Inc. Methods for treating sexual dysfunction
AU2006239302B2 (en) 2005-04-26 2011-07-07 Hypnion, Inc. Benzisoxazole piperazine compounds and methods of use thereof
BRPI0610258A2 (pt) 2005-04-26 2012-09-25 Hypnion Inc composto ou um sal farmaceuticamente eficaz do mesmo, composição farmacêutica, e, uso de um composto
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
CN115304590B (zh) * 2022-09-19 2024-05-28 皮摩尔新药(辽宁)有限公司 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles

Also Published As

Publication number Publication date
CZ255197A3 (cs) 1998-01-14
HUP9800198A2 (hu) 1999-09-28
CN1177297A (zh) 1998-03-25
ES2134709B1 (es) 2000-05-16
ES2134709A1 (es) 1999-10-01
NO973589D0 (no) 1997-08-04
NO973589L (no) 1997-10-08
JPH11501051A (ja) 1999-01-26
FR2742052B1 (fr) 1998-04-10
PL321779A1 (en) 1997-12-22
CA2211161A1 (fr) 1997-06-19
TR199700794T1 (xx) 1997-11-21
AU716665B2 (en) 2000-03-02
AU1376497A (en) 1997-07-03
MX9706133A (es) 1997-11-29
FR2742052A1 (fr) 1997-06-13
IL121461A0 (en) 1998-02-08
EP0808166A1 (fr) 1997-11-26
WO1997021439A1 (fr) 1997-06-19
AR004378A1 (es) 1998-11-04

Similar Documents

Publication Publication Date Title
GB9521537D0 (en) Device and method for the treatment of sleep apnea syndrome
ZA9610457B (en) Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
HUP0002645A3 (en) Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof
AUPN205795A0 (en) Apparatus and methods for treatment of obstructive sleep apnea and/or snoring
EP0705083A4 (en) DEVICE AGAINST SNORING AND BREATHSTILL IN SLEEP
FI954092A7 (fi) Menetelmä hengityslaitteen ohjaamiseksi uniapnean hoidossa
AU4700297A (en) Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
GR3022060T3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
AU3279395A (en) Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU1117092A (en) Treatment of lower urinary tract disorders
DE69528165D1 (de) Transdermal verabreichbare grundlage und daraus hergestelltes transdermal verabreichbares arzneimittel
EP0676200A3 (fr) Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
IL97054A0 (en) Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
IL87524A0 (en) Pharmaceutical preparation for the treatment of sleep disorders and depression comprising a benzothiazole derivative
HUP9802736A3 (en) Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls
ITRM940806A0 (it) Preparato per il trattamento dell'obesita'
NO996060D0 (no) Pusteapparat for behandling av soevnapne
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis
FI953622A0 (fi) Ifenprodiilin ja sen diastereoisomeerien käyttö lääkeaineiden valmistukseen, jotka lääkeaineet ovat käyttökelpoisia perifeeristen neuropatiatilojen ja keskushermoston degeneratiivisten sairauksien hoitoon
AU8195091A (en) Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease
AU4834896A (en) Oral device for the prevention of snoring and sleep apnoea